Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Bessor Pharma LLC currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action represents the entirety of the company's active prosecution workload. The focus on Biotechnology & Pharmaceuticals indicates the specific technical domain where the company is currently seeking patent protection.
The prosecution is handled by 1 distinct examiner located in 1 distinct art unit. This creates a focused interaction between the company and the patent office, as all pending matters are consolidated under one examiner. There is no distribution of examiners or art units for the current pending workload, meaning the outcome of the portfolio's active phase depends on a single administrative path.
GONZALEZ, LUISALBERTO is the busiest examiner for this portfolio with 1 busiest examiner pending action. Because there is only 1 pending office action in total, this examiner is responsible for the current workload. Practitioners working on this portfolio deal exclusively with GONZALEZ, LUISALBERTO for all matters currently awaiting a response from the office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18247573 | Process for the Production of Cannabinol, Cannabinolic Acid, Cannabivarin, Cannabivarinic Acid and Related Cannabinoids | GONZALEZ, LUISALBERTO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18247573 | Process for the Production of Cannabinol, Cannabinolic Acid, Cannabivarin, Cannabivarinic Acid and Related Cannabinoids | GONZALEZ, LUISALBERTO | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18247573 | Process for the Production of Cannabinol, Cannabinolic Acid, Cannabivarin, Cannabivarinic Acid and Related Cannabinoids | GONZALEZ, LUISALBERTO | 1624 | §103§112 | Final Rejection | — | Pending | Mar 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial